Effect of indomethacin on cell cycle proteins in colon cancer cell lines

World Journal of Gastroenterology

Volumn 11, Issue 11, 2005, Pages 1693-1696

  Xu, Mei Hua ^a   Zhang, Gui Ying ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

CDK2; CDK4; Colon cancer; p21WAF1 CIP1; SW480

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; INDOMETACIN; PROTEIN P21; PROTEIN P53;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; COLON CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; DRUG PROTEIN BINDING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING; WILD TYPE;

EID: 17144414956     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i11.1693     Document Type: Article

References (32)

1. Golab J, Kozar K, Kaminski R, Czajka A, Marczak M, Switaj T, Giermasz A, Stoklosa T, Lasek W, Zagozdzon R, Mucha K, Jakobisiak M. Interleukin 12 and indomethacin exert a synergistic, angiogenesis-dependent antitumor activity in mice. Life Sci 2000; 66: 1223-1230
2. Pozzi A, Yan X, Macias-Perez I, Wei S, Hata AN, Breyer RM, Morrow JD, Capdevila JH. Colon carcinoma cell growth is associated with prostaglandin E2/EP4 receptor-evoked ERK activation. J Biol Chem 2004; 279: 29797-29804
3. Kokoska ER, Smith GS, Wolff AB, Deshpande Y, Miller TA. Nonsteroidal anti-inflammatory drugs attenuate epidermal growth factor-induced proliferation independent of prostaglandin synthesis inhibition. J Surg Res 1999; 84: 186-192
4. Yoshimi N, Shimizu M, Matsunaga K, Yamada Y, Fujii K, Hara A, Mori H. Chemopreventive effect of N-(2-cyclohexyloxy-4-nitrophenyl)methane sulfonamide (NS-398), a selective cyclooxygenase-2 inhibitor, in rat colon carcinogenesis induced by azoxymethane. Jpn J Cancer Res 1999; 90: 406-412
5. Cassano G, Gasparre G, Susca F, Lippe C, Guanti G. Lack of effect by prostaglandin F2 alpha on the proliferation of the HCT-8 and HT-29 human adenocarcinoma cell lines. Oncol Rep 2000; 7: 183-186
6. Zhu GH, Wong BC, Ching CK, Lai KC, Lam SK. Differential apoptosis by indomethacin in gastric epithelial cells through the constitutive expression of wild-type p53 and/or upregulation of c-myc. Biochem Pharmacol 1999; 58: 193-200
7. Zhu GH, Wong BC, Eggo MC, Ching CK, Yuen ST, Chan EY, Lai KC, Lam SK. Non-steroidal anti-inflammatory drug-induced apoptosis in gastric cancer cells is blocked by protein kinase C activation through inhibition of c-myc. Br J Cancer 1999; 79: 393-400
8. Kralj M, Kapitanovic S, Kovacevic D, Lukac J, Spaventi S, Pavelic K. Effect of the nonsteroidal anti-inflammatory drug indomethacin on proliferation and apoptosis of colon carcinoma cells. J Cancer Res Clin Oncol 2001; 127: 173-179
9. Bampoe J, Glen J, Hubbard SL, Salhia B, Shannon P, Rutka J, Bernstein M. Adenoviral vector-mediated gene transfer: Timing of wild-type p53 gene expression in vivo and effect of tumor transduction on survival in a rat glioma brachytherapy model. J Neurooncol 2000; 49: 27-39
10. Shetty S, Taylor AC, Harris LC. Selective chemosensitization of rhabdomyosarcoma cell lines following wild-type p53 adenoviral transduction. Anticancer Drugs 2002; 13: 881-889
11. Zhang G, Tu C, Zhang G, Zhong G. Indomethacin induces apoptosis and inhibits proliferation in chronic myeloid leukemia cells. Leuk Res 2000; 24: 385-392
12. Bukholm IK, Nesland JM. Protein expression of p53, p21 (WAF1/CIP1), bcl-2, Bax, cyclin D1 and pRb in human colon carcinomas. Virchows Arch 2000; 436: 224-228
13. Pan MH, Chen WJ, Lin-Shiau SY, Ho CT, Lin JK. Tangeretin induces cell-cycle G1 arrest through inhibiting cyclin-dependent kinases 2 and 4 activities as well as elevating CdK inhibitors p21 and p27 in human colorectal carcinoma cells. Carcinogenesis 2002; 23: 1677-1684
14. Smith ML, Hawcroft G, Hull MA. The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: Evidence of different mechanisms of action. Eur J Cancer 2000; 36: 664-674
15. Kim OH, Lillehaug JR, Vasstrand EN. Influence of p53 and p21Waf1 expression on G2/M phase arrest of colorectal carcinoma HCT116 cells to proteasome inhibitors. Int J Oncol 2004; 24: 935-941
16. WAF1/Cip1 is an antiestrogen-regulated inhibitor of CdK4 in human breast cancer cells. J Biol Chem 2002; 277: 5145-5152
17. Pohl G, Rudas M, Taucher S, Stranzl T, Steger GG, Jakesz R, Pirker R, Filipits M. Expression of cell cycle regulatory proteins in breast carcinomas before and after preoperative chemotherapy. Breast Cancer Res Treat 2003; 78: 97-103
18. Yu B, Lane ME, Wadler S. SU9516, a cyclin-dependent kinase 2 inhibitor, promotes accumulation of high molecular weight E2F complexes in human colon carcinoma cells. Biochem Pharmacol 2002; 64: 1091-1100
19. Bardon S, Foussard V, Fournel S, Loubat A. Monoterpenes inhibit proliferation of human colon cancer cells by modulating cell cycle-related protein expression. Cancer Lett 2002; 181: 187-194
20. Wolter F, Akoglu B, Clausnitzer A, Stein J. Downregulation of the cyclin D1/Cdk4 complex occurs during resveratrol-induced cell cycle arrest in colon cancer cell lines. J Nutr 2001; 131: 2197-2203
21. WAF1 pathway and overexpression of cyclin D1 during squamous differentiation of endometrial carcinoma cells. Am J Pathol 2004; 164: 1739-1749
22. Waf1/Cip1 pathway to inhibit cell proliferation. J Biol Chem 2004; 279: 15161-15166
23. Wu Y, Yan CH, Jin Y, Zhang GY, Li P, Fu SB. Overexpression of p21WAF1 and p53 in human lung adenocarcinoma cell line. Zhongguo Yixuekexueyuan Xuebao 2003; 25: 149-152
24. Park YN, Chae KJ, Kwon KW, Oh BK, Lee KS, Lee WJ, Park C. p53 and p21WAF1/CIP1 in hepatitis B virus related hepatocarcinogenesis. Hepatogastroenterology 2003; 30: 1292-1296
25. waf1, and p53 in node negative invasive ductal breast carcinoma. Mol Pathol 2003; 56 328-335
26. Sasaki Y, Morimoto I, Ishida S, Yamashita T, Imai K, Tokino T. Adenovirus-mediated transfer of the p53 family genes, p73 and p51/p63 induces cell cycle arrest and apoptosis in colorectal cancer cell lines: Potential application to gene therapy of colorectal cancer. Gene Ther 2001; 8: 1401-1408
27. Takahashi A, Ohnishi K, Ota I, Asakawa I, Tamamoto T, Furusawa Y, Matsumoto H, Ohnishi T. p53-dependent thermal enhancement of cellular sensitivity in human squamous cell carcinomas in relation to LET. Int J Radiat Biol 2001; 77: 1043-1051
28. Gao N, Hu YD, Cao XY. The exogenous wild-type p14ARF gene induces growth arrest and promotes radiosensitivity in human lung cancer cell lines. J Cancer Res Clin Oncol 2001; 127: 359-367
29. Riva CM. Restoration of wild-type p53 activity enhances the sensitivity of pleural metastasis to cisplatin through an apoptotic mechanism. Anticancer Res 2000; 20: 4463-4471
30. Bampoe J, Glen J, Hubbard SL, Salhia B, Shannon P, Rutka J, Bernstein M. Adenoviral vector-mediated gene transfer: Timing of wild-type p53 gene expression in vivo and effect of tumor transduction on survival in a rat glioma brachytherapy model. J Neurooncol 2000; 49: 27-39
31. Badie C, Bourhis J, Sobczak-Thepot J, Haddada H, Chiron M, Janicot M, Janot F, Tursz T, Vassal G. p53-dependent G2 arrest associated with a decrease in cyclins A2 and B1 levels in a human carcinoma cell line. Br J Cancer 2000; 82: 642-650
32. Chu EC, Chai J, Tarnawski AS. NSAIDs activate PTEN and other phosphatases in human colon cancer cells: Novel mechanism for chemopreventive action of NSAIDs. Biochem Biophys Res Commun 2004; 320: 875-879